Pochiraju Industries Ltd Stock Analysis

BSE: 532803 | NSE: POCHIRAJU | Floriculture | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Pochiraju Industries

M-Cap below 100cr DeciZen not available


1. Is Pochiraju Industries Ltd. a good quality company?

Data is not available for this company.

2. Is Pochiraju Industries Ltd. undervalued or overvalued?

No data found

3. Is Pochiraju Industries Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Pochiraju Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Pochiraju Industries:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
ROCE % 11.6%11.3%5.7%8.6%3.2%-29.7%-29.5%-7.1%-4.6%-5.1%-
Value Creation Index -0.2-0.2-0.6-0.4-0.8-3.1-3.1-1.5-1.3-1.4-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 55.472.41091201399.700000
YoY Gr. Rt. %-30.7%50.3%10%16.2%-93.1%-100%NANANA-
YoY Gr. Rt. %-26.8%-65%99.3%-88.9%-4588.5%NANANANA-
BVPS (₹) 43.852.153.763.363.936.523.517.715.713.615.2
Adj Net Profit 11.714.
Cash Flow from Ops. 11.713.37.52.645.9-0.10000-
Debt/CF from Ops.


CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales -100%-100%NANA
Adj EPS -188.8%-228.4%NANA
BVPS -12.2-26.6-16.8-13.6
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide
Return on Equity % 12.313.44.380.9-47.2-58.9-27.6-11.5-14-14.7
Op. Profit Mgn % 25.32315.718.66.9-412.800000
Net Profit Mgn %
Debt to Equity
Working Cap Days 18014812217114989000000
Cash Conv. Cycle 14411810013210052500000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Pochiraju Industries Ltd.

Standalone Consolidated
TTM EPS (₹) -2.1 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 15.2 -
Reserves (₹ Cr.) 10 -
P/BV 0.13 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 3.10 / 3.43
All Time Low / High (₹) 2.65 / 88.10
Market Cap (₹ Cr.) 3.7
Equity (₹ Cr.) 18.9
Face Value (₹) 10
Industry PE 300

Management X-Ray of Pochiraju Industries :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes


About Pochiraju Industries Ltd

The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh certificate of incorporation was obtained on September 10, 2003 from Registrar of Companies, Coimbatore

The company is currently focusing on three business segments – Agri Business, Pharmaceuticals and Bio-Technology & Life Sciences. The organizational structure of the company is designed for effective management of multiple business, while retaining focus on each one of them.

Pharmapil is the Pharma Division of PIL, operating its range of pharmaceutical formulations on a national level through aggressive, dynamic and committed field force of over 250 medical representatives. Pharmapil will have two divisions, the General and the Specialty divisions and market products in tablet, capsule, liquid, injectable, powder and ointment dosage forms.

Biopil is the Biotechnology Division of PIL. A state of art plant is under construction spread over 3.86 acres of land in the S. P. Biotechnology Park situated at Turkapally, Shamirpet, Hyderabad. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering and structure based molecular design which are part of modern Biotechnology. The product range shall include biosimilar products, such as Erythropoietin, G-CSF, Interferon Alpha, Interferon Beta, Human Growth Hormone and Recombinant Human Insulin. Biopil will have its own in house Research and Development Laboratory attached to a Common Quality Control, Documentation and Quality Assurance Laboratory.

Agropil is the Agricultural Division of PIL. From a modest start of 3 hectare of green house, it has gradually expanded its floriculture business to 6 hectare of green house and has established its presence in domestic as well as overseas markets. It will be engaged in developing hybrid varieties and genetically modified seeds, bio-fertilizers, bio-pesticides and plant growth stimulants in agriculture

Prouct range of the company include:

Pharma Division

  • Epo
  • Docetaxel
  • Carboplatin
  • Gefitinib
  • Rituximab
  • Oxaliplatin
  • Cisplatin
  • Temozolomide
  • Trastuzimab (Herceptin)
  • Irnotecan
  • 5-Fluorouracil
  • Imatinib
  • Bevacizumab
  • Epirubicin
  • Methotrexate
  • Erlotinib
  • Cetuximab
  • Lipo-Doxorubicine,
  • Tamoxifen

Biotechnology Division

  • Anti Bacterials – Floroquinolones
  • Antibiotics – Macrolides
  • Antibiotics – Betalactums
  • Antibiotics-Injections/Tab - Betalactum & Cephalospori
  • Antifungal drugs
  • Cardiovascular Drugs
  • Antiulcerants
  • N.S.A.I.D
  • Analgesic & Antipyretic
  • Anti spasmodic
  • Proteolytic Enzyme
  • Antihistamines
  • Neutraceuticals

Agricultural Division

Recently the company grown the different varieties of roses consisting different colours such as red, yellow, pink, white, peach etc. The companys flowers and varieties are known for their quality, stem length, bud size with good foliage, free from any pest and disease.

Read More Read Less